Application
F131C Antibody (N-term) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the F131C antibody detected the F131C protein (arrow).Application
F131C Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the F131C Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | F131C Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FAM131C; C1orf117; Protein FAM131C |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C1orf117 |
|---|---|
| Alternative Names | FAM131C C1orf117 Protein FAM131C |
| Molecular Weight(MW) | 30351 Da |
| Tissue Specificity | This F131C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 8-38 amino acids from the N-terminal region of human F131C. |
| Entrez Gene | 348487 |
|---|---|
| Nucleotide Accession | NP_872429.2 |
Application
F131C Antibody (N-term) western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the F131C antibody detected the F131C protein (arrow).
Application
F131C Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the F131C Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
